RSA announces three appointments to its global team
pharmafile | October 11, 2012 | Appointment | | François Martin, Jana Kurtova, Naja Kjeldsen, rsa
Life sciences executive search and interim management specialists RSA has announced three new appointments.
Dr François Martin (pictured) has been made managing director of RSA Switzerland. Martin recently served as senior partner for the Life Sciences and Technology practice for the International Executive Search Federation (IESF).
He brings over 20 years of experience to RSA, having managed large global organisations and projects. Prior to joining IESF he held executive positions at Roche in Switzerland and Japan.
Commenting on his new role he said: “I am delighted to be taking up this position within such a successful company. I am confident that with RSA’s exclusive focus on the life sciences sector along with their professionalism and integrity, together we will be able to continue to build upon the already thriving Swiss business.”
RSA Switzerland also welcomes Dr Naja Kjeldsen who joins as a senior consultant, RSA Interims. A proactive, high achiever in the Life Sciences sector, she has over 20 years of experience where she has worked for leading pharmaceutical organisations.
Kjeldsen set up Stratos Bio in 2002, a business she developed over several years. Whilst there she filed three patents covering the overuse of antibiotics and their potential carcinogenic side effects.
Previously she worked as a project management director in Interim Management for Lundbeck, where she was responsible for portfolio management.
Jana Kurtova joins RSA’s UK team as a senior consultant, RSA Interims. A creative thinker with a global perspective, Kurtova’s background includes business development, strategy development and implementation, team leadership and project management.
Previously Kurtova was Head of PULSE Life Sciences where she led two teams and built a new team in London. Prior to this she was the regional director of Hays Life Sciences where she launched new divisions in Moscow, Shanghai, Beijing, Singapore and Mumbai.
Commenting on the new appointments, John Callagher, chief executive of RSA said: “We are proud to have secured such talented individuals and we welcome them into the RSA family. We hope that we can provide all new members of the team with the right platform to further develop their knowledge and expertise as we continue to expand and develop the business in new ways.”
Related Content
Hold your horses: M&A is about talent, not just pipelines
The morning mist is rising on the battlefield. At stake: the crown riches and glory …
Addressing the boardroom gender gap
The issue of gender balance within UK boards has moved quickly up the business agenda …
UK pharma downbeat on its future – survey
The impacts of NHS reform and the increasingly high cost of R&D is causing pharma …
